Clinical Trial Update: A Placebo-Controlled Phase 3 Trial of Repeated Lamazym Treatment of Subjects With Alpha-Mannosidosis [Phase 3]

View source ↗

Summary

A randomized, placebo-controlled Phase 3 trial evaluating repeated Lamazym treatment in subjects with alpha-mannosidosis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-mannosidosis

Drugs mentioned

• Lamazym

Snippet

Sponsor: Zymenex A/S | Conditions: Alpha-Mannosidosis | Phase 3 | Status: COMPLETED